| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000045147 |
| Receipt No. | R000051438 |
| Scientific Title | Prognostic effects of the differences in histopathological evaluation between preoperative chemotherapy with Docetaxel, CDDP and 5-FU and preoperative chemoradiotherapy in locally advanced esophageal squamous cell carcinoma of Stage III or higher : a retrospective study in a single institution |
| Date of disclosure of the study information | 2021/10/01 |
| Last modified on | 2021/08/13 (Ver. 1) |
| Basic information | ||
| Public title | Prognostic effects of the differences in histopathological evaluation between preoperative chemotherapy and preoperative chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma | |
| Acronym | Pathological evaluation and remote results of preoperative chemotherapy versus chemoradiotherapy in advanced esophageal cancer | |
| Scientific Title | Prognostic effects of the differences in histopathological evaluation between preoperative chemotherapy with Docetaxel, CDDP and 5-FU and preoperative chemoradiotherapy in locally advanced esophageal squamous cell carcinoma of Stage III or higher : a retrospective study in a single institution
|
|
| Scientific Title:Acronym | Histopathological evaluation and treatment results of preoperative DCF and preoperative CRT for advanced esophageal cancer | |
| Region |
|
|
| Condition | ||||
| Condition | esophageal cancer | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Malignancy | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | The retrospective analyses were performed for two different cohorts of preoperative DCF and preoperative CRT in locally advanced esophageal cancer, and in particular, the results of histopathological effect evaluation from surgical specimens were analyzed for the two cohorts. By doing so, we will consider the ideal form of neoadjuvant therapy, the positioning of surgery, and even better surgical methods. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | To systematically examine the difference in histopathological evaluation between preoperative DCF and preoperative CRT and in the remote results of the cohorts |
| Key secondary outcomes | To clarify the central role of surgery in the multidisciplinary treatment by presenting the remote results of surgery alone performed without overlapping the patient registration period of preoperative chemotherapy and preoperative CRT cohorts. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients with esophageal squamous cell carcinoma in the pretreatment pathological diagnosis.
2.Patients without simultaneous advanced another cancer. 3.Patients It is resistant to surgery in terms of general condition, cardiopulmonary function, and hepato-renal function. 4.Patients to be the candidates of chemotherapy / chemoradiotherapy 5.Patients with UICC7th cT3 or deeper but borderline excision ability , or cT3N1-3. 6.Patients undergoing radical surgery |
|||
| Key exclusion criteria | 1. No pretreatment pathological diagnosis.
2. Simultaneous advanced another cancer. 3. Anxiety about surgical tolerance before treatment. 4. Chemotherapy cannot be performed due to organ function. 5. Although registered in each cohort before the start of preoperative treatment cases in which the actual surgery was not performed due to reasons including side effects of preoperative treatment, tumor regrowth during preoperative treatment and refusal of the patient. |
|||
| Target sample size | 300 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Keiyukai Sapporo Hospital | ||||||
| Division name | Department of Radiation Oncology | ||||||
| Zip code | 0030026 | ||||||
| Address | Minami 1-1, Hondori-9, Shiroishi-ku, Sapporo | ||||||
| TEL | +8111-863-2101 | ||||||
| miyako98kazm@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Keiyukai Sapporo Hospital | ||||||
| Division name | Department of Radiation Oncology | ||||||
| Zip code | 003-0026 | ||||||
| Address | Minami 1-1, Hondori-9, Shiroishi-ku, Sapporo | ||||||
| TEL | +81-11-863-2101 | ||||||
| Homepage URL | |||||||
| miyako98kazm@gmail.com | |||||||
| Sponsor | |
| Institute | others
Keiyukai Sapporo Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Keiyukaisapporo hospital ethics commitee |
| Address | Minami 1-1, Hondori-9, Shiroishi-ku, Sapporo |
| Tel | +81-11-863-2101 |
| miyako@keiyukaisapporo.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 132 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Observation study about relationship between histopathological evaluation of neoadjuvant therapy and surgical procedures and long-term survival.
|
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051438 |